Your browser doesn't support javascript.
loading
Could proteasome inhibition improve therapeutic vaccine response in HIV?
Cummins, Nathan W; Badley, Andrew D.
Affiliation
  • Cummins NW; Section of Infectious Diseases, Mayo Clinic, Rochester, MN, United States. Electronic address: Cummins.nathan@mayo.edu.
  • Badley AD; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, United States.
Vaccine ; 40(26): 3514-3515, 2022 06 09.
Article in En | MEDLINE | ID: mdl-35570076
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines / HIV Infections / HIV-1 Limits: Humans Language: En Journal: Vaccine Year: 2022 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vaccines / HIV Infections / HIV-1 Limits: Humans Language: En Journal: Vaccine Year: 2022 Document type: Article Country of publication: